Bayer Aktiengesellschaft
BAYN
株式のランク
#490
Bayer Aktiengesellschaft operates as a life science company in Europe, the... Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
株価
$50.31
最終同期: 2026-10-21
時価総額
$49.43B
変化（1日）
-2.45%
変化（1年）
57.43%
国
DE
取引 Bayer Aktiengesellschaft (BAYN)
カテゴリー
Healthcare
Bayer Aktiengesellschaft（BAYN）の発行済株式数
October 2026 時点の発行済株式数 0
Bayer Aktiengesellschaft の最新の財務報告および株価によると、現在の発行済株式数は 0 です。October 2026 の終わりには、同社は 0 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Bayer Aktiengesellschaft（BAYN）の発行済株式数の履歴（2026 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 提供された日付のデータは十分ではありません。 | ||
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 892.40M | - |
US
|
|
| 2.45B | - |
US
|
|
| 1.77B | - |
US
|
|
| 0.00 | - |
US
|
|
| 796.00M | - |
CH
|
